报告题目：单细胞生物传感及临床应用

报告人：丁显廷 教授  上海交通大学

主持人： 吴幸 教授

报告时间：2020年11月13日下午14:00

报告地点：闵行信息楼133会议室

报告摘要：

Bio-complex systems involve layers of signaling molecules from genomics to proteomics to metabolomics to immunology and to phenology. A diseased system often recruits an ensemble of signaling targets with aberrant expressions. However, the available blood or tissue sample from a patient is usually trace amount, which is extremely challenging for multi-omics multi-targets analysis with conventional techniques. Our group has two major research focuses: 1) disease diagnostics by detecting multiple disease-correlated targets simultaneously to enable super-early disease diagnostics; 2) disease therapeutics by manipulating multiple disease-correlated targets simultaneously to develop potent combinatorial drug therapy. To achieve these research impetuses, many challenging problems related to physics, engineering, chemistry, mathematics and biomedical applications need to be overcome.

报告人简介：

丁显廷，上海交通大学教授，博士生导师，生物医学工程学院分子与纳米医学平台主任，个性化医学研究院常务副院长。科研方向主要面向国防安全和社会应用开发基于痕量生物样本的个体化诊疗技术：1．痕量临床样本检验新原理和新技术；2.痕量临床样本检验装置的集成化和微型化；3.基于痕量临床样本的药物敏感性检测技术。目前担任20个国际SCI期刊审稿人，6个国际SCI期刊的编委会成员，已发表包括ScienceAdvances, Genome Biology, Advanced Functional Materials, Biosensors &Bioelectronics, Nature Communications, PNAS, Nature Protocols, AnalyticalChemistry在内的国际期刊论文100余篇，申请国内外发明专利30余项。